Treatment of Priapism
The treatment of ischemic priapism should follow a stepwise approach, beginning with intracavernosal phenylephrine injection with or without aspiration/irrigation, followed by surgical shunting procedures if medical management fails. 1
Diagnosis and Classification
Priapism is defined as a persistent penile erection lasting more than 4 hours without sexual stimulation. Proper management requires distinguishing between two main types:
Ischemic (low-flow) priapism (95% of cases):
- Characterized by painful, rigid erection
- Blood gas values: PO₂ <30 mmHg, PCO₂ >60 mmHg, pH <7.25
- Urological emergency requiring immediate intervention
Non-ischemic (high-flow) priapism (5% of cases):
- Usually painless
- Normal blood gas values
- Often associated with perineal trauma
- Not a medical emergency
Treatment Algorithm for Ischemic Priapism
First-Line Treatment
Aspiration with or without irrigation:
- Insert 19-21 gauge butterfly needle into lateral aspect of proximal penis
- Aspirate old, dark blood
- May include irrigation with normal saline
- Resolution rate: approximately 30% 2
Intracavernosal injection of phenylephrine:
Second-Line Treatment (if first-line fails)
Surgical shunting procedures:
Distal (cavernoglanular) shunts (first choice):
- Winter procedure (needle-based)
- Ebbehøj procedure (scalpel-based)
- Al-Ghorab procedure (excision of tunica albuginea at tip)
- Resolution rates: 66-74% 2
- Lower erectile dysfunction rates (≤25%) compared to proximal shunts
Proximal shunts (if distal shunts fail):
- Quackels procedure (cavernospongious)
- Grayhack procedure (cavernosaphenous)
- Resolution rates: 76-77% 2
- Higher erectile dysfunction rates (approximately 50%)
Treatment for Non-ischemic Priapism
- Initial management: Observation (not an emergency)
- If treatment requested: Selective arterial embolization
Special Considerations
Priapism with Underlying Disorders (e.g., Sickle Cell Disease)
- Treat the priapism first with standard urologic interventions
- Provide concurrent systemic treatment for the underlying disease
- Do not delay penile-directed therapy while waiting for systemic treatments
- Systemic treatments alone have poor resolution rates (0-37%) 2, 1
Duration-Based Approach
- <4 hours: Intracavernosal phenylephrine alone may be sufficient
- 4-24 hours: Aspiration/irrigation with phenylephrine injection
- 24-48 hours: Begin with aspiration/irrigation and phenylephrine, lower threshold for surgical shunting
- >48 hours: Consider aggressive approaches including surgical shunting
- >72 hours: Sympathomimetics less effective; surgical shunting often required 2
Common Pitfalls to Avoid
- Delaying treatment - Untreated ischemic priapism >36 hours has high likelihood of permanent erectile dysfunction
- Using epinephrine instead of phenylephrine - Higher risk of cardiovascular side effects
- Not monitoring vital signs during sympathomimetic administration
- Proceeding to surgical shunting before adequate trials of phenylephrine and aspiration/irrigation
- Treating non-ischemic priapism with aspiration and sympathomimetics (ineffective and potentially harmful)
- Relying solely on systemic treatments for priapism associated with hematologic disorders
Follow-up Care
- Schedule follow-up to assess erectile function recovery
- Counsel patients regarding potential need for future erectile dysfunction treatments
- Consider evaluation for underlying causes (medications, hematologic disorders, malignancies)
Remember that prompt intervention is crucial for ischemic priapism to preserve erectile function, while non-ischemic priapism can often be managed conservatively.